Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: A randomized clinical trial

American Journal of Clinical Nutrition

Volumn 92, Issue 4, 2010, Pages 723-732

  Wolever, Thomas M S ^a   Tosh, Susan M ^b   Gibbs, Alison L ^c   Brand Miller, Jennie ^d   Duncan, Alison M ^e   Hart, Valerie ^f   Lamarche, Benoît ^g   Thomson, Barbara A ^h   Duss, Ruedi ⁱ   Wood, Peter J ^b  

^a Glycemic Index Laboratories Inc   (Canada)

^b AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF GUELPH   (Canada)

^f Reading Scientific Services Ltd   (United Kingdom)

^g LAVAL UNIVERSITY   (Canada)

^h Thomson Data Analysis   (Canada)

ⁱ CreaNutrition AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT;

ADULT; ARTICLE; CEREAL; CHOLESTEROL BLOOD LEVEL; DIETARY FIBER; DOUBLE BLIND PROCEDURE; FEMALE; FOOD COMPOSITION; HUMAN; MALE; MOLECULAR WEIGHT; MULTICENTER STUDY; OAT; PARALLEL DESIGN; PHYSICAL CHEMISTRY; RANDOMIZED CONTROLLED TRIAL; WHEAT; AGED; BLOOD; CALORIC INTAKE; CARBOHYDRATE DIET; CHOLESTEROL INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FAT INTAKE; MIDDLE AGED;

TRITICUM AESTIVUM;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; AVENA SATIVA; BETA-GLUCANS; CEREALS; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY FIBER; DOUBLE-BLIND METHOD; ENERGY INTAKE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; TRITICUM;

EID: 78049420555     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2010.29174     Document Type: Article

References (54)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 2002;106:3143-2.
2. Pedersen TR, Faergeman O, Kastelein JJ, et al. Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 2005;294:2437-45.
3. Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis. Clin Ther 2009;31:236-44.
4. Bazzano LA, He J, Ogden LG, Loria CM, Whelton PK. Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 2003;163:1897-904.
5. Anderson JW, Deakins DA, Floore TL, Smith BM, Whitis SE. Dietary fiber and coronary heart disease. Crit Rev Food Sci Nutr 1990;29:95-147.
6. Davidson MH, Dugan LD, Burns JH, Bova J, Story K, Drennan KB. The hypo-cholesterolemic effects of β-glucan in oatmeal and oat bran. JAMA 1991;265:1833-9.
7. Ripsin CM, Keenan JM, Jacobs DR, et al. Oat products and lipid lowering - a meta analysis. JAMA 1992;267:3317-25.
8. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69:30-42.
9. Braaten JT, Wood PJ, Scott FW, et al. Oat β-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994;48:465-74.
10. Berg A, König D, Deibert P, et al. Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. Ann Nutr Metab 2003;47:306-11.
11. Amundsen ÅL, Haugum B, Andersson H. Changes in serum cholesterol and sterol metabolites after intake of products enriched with an oat bran concentrate within a controlled diet. Scand J Clin Nutr 2003;47:68-74.
12. Karmally W, Montez MG, Palmas W, et al. Cholesterol-lowering benefits of oat-containing cereal in Hispanic Americans. J Am Diet Assoc 2005;105:967-70.
13. Theuwissen E, Mensink RP. Simultaneous intake of β-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemia subjects. J Nutr 2007;137:583-8.
14. Anonymous. Food labeling: health claims; oats and coronary heart disease. Fed Regist 1997;62:3584-601.
15. European Food Safety Authority (EFSA) Panel on Dietetic Products. Nutrition and allergies (NDA). Scientific opinion on the substantiation of health claims related to beta-glucans and maintenance of normal blood cholesterol concentrations. EFSA J 2009;7:1254.
16. French Food Safety Agency. de l'Agence française de sécurité sanitaire des aliments relatif à la demande d'évaluation du fondement scientifique de l'allégation relative à l'effet des fibres solubles d'avoine consommées au sein d'un régime adapté sur le cholestérol sanguin. Available from: http://www.afssa.fr/Documents/NUT2007sa0168.pdf (cited 2 November 2009).
17. Joint Health Claims Initiative Expert Committee. Generic claim submission in relation to oat beta-glucan and cholesterol reduction. Available from: http://www.jhci.org.uk/approv/oats.htm (cited 2 November 2009).
18. Lovegrove JA, Clohessy A, Milon H, Williams CM. Modest doses of β-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr 2000;72:49-55. (Pubitemid 30441656)
19. Chen J, He J, Wildman RP, Reynolds K, Streiffer RH, Whelton PK. A randomized controlled trial of dietary fiber intake on serum lipids. Eur J Clin Nutr 2006;60:62-8. (Pubitemid 43731076)
20. Wood PJ, Beer MU, Butler G. Evaluation of role of concentration and molecular weight of oat β-glucan in determining effect of viscosity on plasma glucose and insulin following an oral glucose load. Br J Nutr 2000;84:19-23.
21. Regand A, Tosh SM, Wolever TMS, Wood PJ. Physicochemical properties of beta-glucan in differently processed oat foods influence glycemic response. J Agric Food Chem 2009;57:8831-8.
22. Gallaher DD, Hassel CA, Lee K-J. Relationship between viscosity of hydroxypropyl methylcellulose and plasma cholesterol in hamsters. J Nutr 1993;123:1732-8.
23. Reppas C, Swidan SZ, Tobey SW, Turowski M, Drressman JB. Hydroxymethylcellulose significantly lowers blood cholesterol in mildly hypercholesterolemic human subjects. Eur J Clin Nutr 2009;63:71-7.
24. Poppitt SD. Soluble fibre oat and barley β-glucan enriched products: can we predict cholesterol-lowering effects? Br J Nutr 2007;97:1049-50.
25. Jenkins DJA, Wolever TMS, Leeds AR, et al. Dietary fibres, fibre analogues and glucose tolerance: importance of viscosity. BMJ 1978;1:1392-4.
26. Wood PJ, Braaten JT, Scott FW, Riedel KD, Wolynetz MS, Collins MW. Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br J Nutr 1994;72:731-43.
27. Tosh SM, Brummer Y, Wolever TMS, Wood PJ. Glycemic response to oat bran muffins treated to vary the molecular weight of the beta-glucan. Cereal Chem 2008;85:211-7.
28. Lan-Pidhainy X, Brummer Y, Tosh SM, Wolever TMS, Wood PJ. Reducing beta-glucan solubility in oat bran muffins by freeze-thaw treatment attenuates its hypoglycemic effect. Cereal Chem 2007;84:512-7.
29. Schultz KF, Grimes DA. Allocation concealment in randomized trials: defending against deciphering. Lancet 2002;359:614-8.
30. Schultz KF, Grimes DA. Unequal group sizes in randomized trials: guarding against guessing. Lancet 2002;359:966-70.
31. Anonymous. AOAC official methods of analysis 18th Ed. AOAC International, Gaithersburg, MD. 2005. Available from: www.eoma.aoac. org (cited 4 December 2009).
32. Beer MU, Wood PJ, Weisz J, Fillion N. Effect of cooking and storage on the amount and molecular weight of (1→3)(1→4)-D-β-glucan extracted from oat products by an in vitro digestion system. Cereal Chem 1997;74:705-9.
33. Tosh SM, Brummer Y, Shea Miller S, et al. Processing affects physicochemical properties of β-glucan in oat bran cereal. J Agric Food Chem 2010;58:7723-30.
34. Wolever TMS, Chiasson JL, Josse RG, et al. No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care 1998;21:1612-8.
35. Wolever TMS, Gibbs AL, Mehling C, et al. The Canadian trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 2008;87:114-25.
36. Nakagawa S. A farewell to Bonferroni: the problems of low statistical power and publication bias. Behav Ecol 2004;15:1044-5.
37. Aggett PJ, Antoine J-M, Asp N-J, et al. PASSCLAIM: process for the assessment of scientific support for claims on foods: consensus on criteria. Eur J Nutr 2005;44(suppl 1):I/1-I/30.
38. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366:1267-78. (Published erratum appears in Lancet 2005;366: 1358 and Lancet 2008;371:2084.)
39. Lia Å, Andersson H, Mekki N, Juhel C, Senft M, Lairon D. Postprandial lipemia in relation to sterol and fat excretion in ileostomy subjects given oat-bran and wheat test meals. Am J Clin Nutr 1997;66:357-65.
40. Marlett JA, Hosig KB, Vollendorf NW, Shinnick FL, Haack VS, Story JA. Mechanism of serum cholesterol reduction by oat bran. Hepatology 1994;20:1450-7.
41. Biörklund M, van Rees A, Mensink RP, Önning G. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with β-glucans from oats or barley: a randomized dose-controlled trial. Eur J Clin Nutr 2005;59:1272-81.
42. Keenan JM, Goulson M, Shamliyan T, Knutson N, Kolberg L, Curry L. The effects of concentrated barley β-glucan on blood lipids in a population of hypercholesterolaemic men and women. Br J Nutr 2007;97:1162-8.
43. Smith KN, Queenan KM, Thomas W, Fulcher G, Slavin JL. Physiological effects of concentrated barley β-glucan in mildly hypercholesterolemic adults. J Am Coll Nutr 2008;27:434-40.
44. Ren Y, Ellis PR, Ross-Murphy SB, Wang Q, Wood PJ. Dilute and semi-dilute solution properties of (1→3), (1→4)-β-D-glucan, the endosperm cell wall polysaccharide of oats (Avena sativa L.). Carb Polymers 2003;53:401-8.
45. 13C CP/MAS NMR spectroscopy and AFM study of the structure of Glucogel, a gelling β-glucan from barley. Carbohydr Res 1999;315:169-79.
46. Morgan KR, Ofman DJ. Glucagel, a gelling β-glucan from barley. Cereal Chem 1998;75:879-81.
47. Izydorczyk MS, Dexter JE. Barley β-glucans and arabinoxylans: molecular structure, physicochemical properties, and uses in food products-a review. Food Res Int 2008;41:850-68.
48. Naumann E, van Rees AB, Önning G, Öste R, Wydra M, Mensink RP. β-glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations. Am J Clin Nutr 2006;83:601-5.
49. Keogh GF, Cooper GJS, Mulvey TB, et al. Randomized controlled crossover study of the effect of a highly β-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 2003;78:711-8.
50. Biörklund M, Holm J, Önning G. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat β-glucan-containing ready meal. Ann Nutr Metab 2008;52:83-90.
51. Cugnet-Anceau C, Nazare J-A, Biorklund M, et al. A controlled study of consumption of β-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Br J Nutr 2010;103:422-8.
52. Andersson AAM, Armö E, Grangeon E, Fredriksson H, Andersson R, Åman P. Molecular weight and structure units of (1→3, 1→4)-β-glucans in dough and bread made from hull-less barley milling fractions. J Cereal Sci 2004;40:195-204.
53. Kestin M, Moss R, Clifton PM, Nestel PJ. Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. Am J Clin Nutr 1990;52:661-6.
54. Liatis S, Tsapogas P, Chala E, et al. The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes. Diabetes Metab 2009;35:115-20.